OptimizeRx (OPRX) Q1 2024 Annual Earnings
OPRX·Reported May 14, 2024·After market close
OptimizeRx reported Q1 2024 revenue of $19.7M, beat analyst consensus of $18.1M by $1.6M. Diluted EPS came in at $-0.11.
Revenue
$19.7Mbeat by $1.6M
Consensus: $18.1MDiluted EPS
$-0.11met estimate
Consensus: $-0.11
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about OptimizeRx's Q1 2024 earnings report.
OptimizeRx (OPRX) reported Q1 2024 earnings on May 14, 2024 after market close.
OptimizeRx reported revenue of $19.7M and diluted EPS of $-0.11 for Q1 2024.
Revenue beat the consensus estimate of $18.1M by $1.6M. EPS beat the consensus estimate of $-0.11 by $0.00.
You can read the 10-K periodic report (0001213900-24-033000) directly on SEC EDGAR. The filing index links above go to sec.gov.